Log In
Print this Print this

Jakafi, Jakavi, ruxolitinib (INCB18424)

Also known as: INC424, INCB018424

  Manage Alerts
Collapse Summary General Information
Company Incyte Corp.
DescriptionOral Janus kinase-1 (JAK-1) and JAK-2 inhibitor
Molecular Target Janus kinase-1 (JAK-1) ; Janus kinase-2 (JAK-2)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor; Janus kinase-1 (JAK-1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today